"We advocate a framework agreement model without subsequent negotiation in hospitals"

The General Director of BioSim, Regina Múzquiz, speaks in an interview with the newspapers El Global and Gaceta Médica about the main issues of interest related to biosimilars. Among other topics, current issues are addressed such as the therapeutic contribution that they represent for patients, professionals and health organizations; BioSim's proposals on market entry models and acquisition criteria that favor their adequate presence in healthcare processes; the challenges of disseminating knowledge of these medicines to professionals: and, finally, the activities carried out by the Association. The content of the interview can be accessed at the accompanying link.

READ MORE